Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of key signaling pathways and novel computational drug target for oral cancer, metabolic disorders and periodontal disease

22 Oct 2024

Abstract excerpt

AIM: Due to conventional endocrinological methods, there is presently no shared work available, and no therapeutic options have been demonstrated in oral cancer (OC) and periodontal disease (PD), type 2 diabetes (T2D), and obese patients. The aim of this study is to determine the similar molecular pathways and potential therapeutic targets in PD, OC, T2D, and obesity that may be used to anticipate the progression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Research and Disease Studies
Share to Ferroptosis and cancer prognosis
Share to Oral Health Pathology and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39674633
DOI: 10.1016/j.jgeb.2024.100431

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of key signaling pathways and novel computational drug target for oral cancer, metabolic disorders and periodontal diseasePMID 39674633Read ↗

Explore Novel Biomarkers and Associated Key Pathways to Perform as Potential Prognostic Biomarkers and Therapeutic Targets in Oral CancerSemantic proximity Read ↗

Bioinformatics Analysis of Key Genes and Pathways for Obesity Associated Type 2 Diabetes Mellitus as a Therapeutic TargetSemantic proximity Read ↗

Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancerSemantic proximity Read ↗

Identification of key biomarkers associated with oral squamous cell carcinoma prognosis and immune responseSemantic proximity Read ↗

Investigation of Candidate Genes and Mechanisms Underlying Obesity Associated Type 2 Diabetes Mellitus Using Bioinformatics Analysis and Screening of Small Drug Molecules Semantic proximity Read ↗

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.Semantic proximity Read ↗

Single-Cell RNA Sequencing Analysis of Key Candidate Genes; Molecular Modeling and Docking-Based Therapeutic Molecules Exploration of Nature Derived Phytoconstituents for Type 2 Diabetes Mellitus.Semantic proximity Read ↗

Network Analysis of Genes and Identification of Candidate Drug Compound for Associated Deadly Diseases of FemaleSemantic proximity Read ↗

Bioinformatics and Next-Generation Data Analysis for Identification of Genes and Molecular Pathways Involved in Subjects with Diabetes and ObesitySemantic proximity Read ↗

Network Analysis of Genes and Identification of Candidate Drug Compounds for Associated Deadly Diseases of FemalesSemantic proximity Read ↗

Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysisSemantic proximity Read ↗

Integrative Bioinformatics Approaches to Map Potential Novel Genes and Pathways Involved in Ovarian CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.